… Ursula Scheffel, BuckA. Rhodes, TK Natarajan, and Henry N. Wagner, Jr. … For reprints
contact: Ursula Scheffel, Dept. of Radio logical Science, The Johns Hopkins Medical …

Imaging of glutamate carboxypeptidase II (GCP II), also known as N-acetylated α-linked l-amino
dipeptidase (NAALADase), may enable study of glutamatergic transmission, prostate …

Potent antagonists of bombesin-like peptides have shown great potential for applications in
cancer therapy. A 99m Tc-labeled agent capable of identifying patients who could benefit …

The present study evaluated short‐ and long‐term effects of MDMA (3,4‐methylenedioxymethamphetamine)
in the baboon brain using PET and [ 11 C](+)McN 5652, a potent 5‐HT …

This paper presents the first Positron Emission Tomography (PET) images of the serotonin (5‐hydroxytryptamine,
5‐HT) transporter in the living human brain. PET imaging was …

The development of the radioligands for PET imaging of the cerebral cannabinoid receptor (CB1)
is of great importance for studying its role in neuropsychiatric disorders, obesity, and …

[ 11 C]WIN 35,428 was evaluated as a specific in vivo radioligand for the dopamine transporter
site by PET scanning in nonhuman primates and humans. In studies with a baboon (…

There has been considerable interest in the development of a PET radioligand selective for
the serotonin (5-hydroxytryptamine [5-HT]) transporter (SERT) that can be used to image 5-…

The in vivo behavior of the stereoisomers of [ 11 C]McN5652, a highly potent serotonin (5-HT)
uptake blocker, was determined to evaluate their utility as radiotracers for imaging 5-HT …

N1‐([ 11 C]‐Methyl)‐2‐Br‐LSD ([ 11 C]‐MBL) has been developed as a positron emission
tomography (PET) imaging agent for serotonin 5‐HT 2 receptors. In vitro receptor binding …